Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    AYAs with cancer receive aggressive EOL care

    Author:
    HT Staff
    Publish date: July 10, 2015

    patient and her father Photo by Rhoda Baer In a retrospective study, a majority of adolescents and young adults (AYAs) with terminal cancer...

    • Read More

    News

    How B-cell lymphoma evades NK cells

    Author:
    HT Staff
    Publish date: July 10, 2015

    Image by Joshua Strokes Researchers say they have determined how lymphoma cells evade natural killer (NK) cells, and this discovery has revealed...

    • Read More

    News

    Combo shows potential for treating PEL

    Author:
    HT Staff
    Publish date: July 9, 2015

    reviewing an image Photo from the University of Southern California Immunomodulatory drugs (IMiDs) and BRD4 inhibitors hold promise for treating...

    • Read More

    News

    Model helps explain chaotic angiogenesis

    Author:
    HT Staff
    Publish date: July 9, 2015

    Image by Louis Heiser and Robert Ackland Scientists say they have developed a model that provides new insight into chaotic angiogenesis, a...

    • Read More

    News

    Sepsis readmissions common and costly, group says

    Author:
    HT Staff
    Publish date: July 9, 2015

    Photo courtesy of the CDC Hospital readmissions for sepsis are under-recognized, and additional measures are needed to prevent these readmissions...

    • Read More

    News

    Early progression predicts overall survival in FL

    Author:
    HT Staff
    Publish date: July 9, 2015

    Photo by Rhoda Baer The goal for many cancer patients is to reach the 5-year mark without progression, but a new study suggests 2 years might be a...

    • Read More

    News

    Benefit of extended anticoagulation is temporary, study shows

    Author:
    HT Staff
    Publish date: July 8, 2015

    Results of the PADIS-PE trial suggest that patients with a first episode of pulmonary embolism (PE) benefit from extended anticoagulation therapy...

    • Read More

    News

    Drug may fight cancer by suppressing inflammation

    Author:
    HT Staff
    Publish date: July 8, 2015

    Intermittent dosing with the immunosuppressant rapamycin can break an inflammatory loop that fuels cancer relapse, according to researchers. The...

    • Read More

    News

    NICE wants more info on PI3Kδ inhibitor

    Author:
    HT Staff
    Publish date: July 8, 2015

    The UK’s National Institute for Health and Care Excellence (NICE) has opened a consultation on a preliminary draft guidance for the PI3Kδ...

    • Read More

    News

    Methotrexate could treat MPNs cheaply, team says

    Author:
    HT Staff
    Publish date: July 7, 2015

    Photo courtesy of the National Cancer Institute Preclinical research suggests the antineoplastic agent methotrexate (MTX) could be used to treat...

    • Read More

    News

    EAP makes drug available to MM patients

    Author:
    HT Staff
    Publish date: July 7, 2015

    Photo by Linda Bartlett A new expanded access program (EAP) will make daratumumab, an investigational anti-CD38 monoclonal antibody, available to...

    • Read More

    News

    NICE supports use of apixaban for VTE

    Author:
    HT Staff
    Publish date: July 7, 2015

    Photo courtesy of the CDC The UK’s National Institute for Health and Care Excellence (NICE) has issued a final guidance recommending the...

    • Read More

    News

    Healthcare professionals work while sick despite risk to patients

    Author:
    HT Staff
    Publish date: July 7, 2015

    Photo by Logan Tuttle Results of a small survey showed that many healthcare professionals reported to work while sick, despite recognizing that...

    • Read More

    News

    PI3K inhibitors may promote cancer spread

    Author:
    HT Staff
    Publish date: July 4, 2015

    Photo courtesy of The Wistar Institute Although PI3K inhibitors have been designed to treat cancer, new research indicates these drugs may...

    • Read More

    News

    Inhibitors increase burden of hemophilia care

    Author:
    HT Staff
    Publish date: July 3, 2015

    TORONTO—When children with hemophilia develop inhibitors, their caregivers shoulder a greater burden, according to a pilot study. Researchers...

    • Read More

    Pages

    • « first
    • …
    • 169
    • 170
    • 171
    • 172
    • 173
    • 174
    • 175
    • 176
    • 177
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery